Promoting HIV Testing and Linkage to Care in Cross-Border Migrants in Lesotho
促进莱索托跨境移民的艾滋病毒检测及其与护理的联系
基本信息
- 批准号:10483680
- 负责人:
- 金额:$ 19.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAIDS/HIV problemAcquired Immunodeficiency SyndromeAdherenceAffectAfrica South of the SaharaAfricanAgeAgricultural WorkersAppointmentAutomobile DrivingAwarenessBeliefCOVID-19COVID-19 pandemicCOVID-19 pandemic effectsCaringCharacteristicsClinicClinicalCollaborationsCommunitiesConsentContinuity of Patient CareCountryCustomDataDevelopmentDiagnostic Reagent KitsEconomicsEmploymentEpidemicEventFaceFemaleFocus GroupsFundingFutureGoalsHIVHIV InfectionsHIV SeropositivityHealthHealth Services AccessibilityHealth care facilityHealth systemHealthcareHigh PrevalenceHuman immunodeficiency virus testIndividualInterruptionInterventionInterviewKnowledgeLabor MigrationsLegalLesothoLife StyleLinkLocationMeasuresMeta-AnalysisMethodsMigrantMigrant WorkersNonmigrantOutcomeParticipantPersonsPhasePoliciesPopulationPrevalencePreventionPrivacyPublic HealthRecommendationRecording of previous eventsReportingResearchScienceServicesSouth AfricaState InterestsStrategic PlanningSurveysTestingTypologyUnited States National Institutes of HealthViralViral Load resultVulnerable Populationsage groupantiretroviral therapybarrier to carebaseeligible participantexperienceexperimental studyhealth care availabilityhealth disparityhealth service usehome testimprovedinnovationinnovative technologiesmalemenmigrationmultidisciplinarypopulation basedpreferenceprevention servicerecruitresponseself testingsexsocialsocial exclusionstakeholder perspectivessupport toolstesting accesstesting servicestesting uptaketreatment servicesuptake
项目摘要
PROJECT SUMMARY/ABSTRACT
In this R21 application (PA-20-145: Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize
HIV Prevention and Care Continuum Outcomes), we propose to explore the use of community or home-based
testing, including self-testing (HIVST) and preferences for linkage to confirmatory testing and treatment in cross-
border migrants in Lesotho, a country with very high HIV prevalence as well as high rates of mobility. Through our
research done as part of the Lesotho Population-based HIV Impact Assessment (LePHIA) in 2020, we found that
Lesotho has made great gains in terms of HIV viral load suppression overall, but those who had recently migrated
were significantly less likely to be virally suppressed, mainly due to lack of awareness. The Ministry of Health has
been rolling out HIVST as a strategy to reach men and populations who do not normally access health care.
However, an increase in testing is insufficient as a public health strategy if the barriers to treatment mean that
knowledge of status does not translate into engagement in antiretroviral treatment and viral suppression,
diminishing the clinical and epidemic control benefits. In order to determine the best strategy for increasing testing
and linkage to treatment rates in migrants, we aim to determine preferences for confirmatory testing and treatment
in cross-border migrants who report that HIV testing outside the facility is acceptable. First, we will conduct
formative research to explore determinants of migrant health and to understand the barriers and facilitators to
testing and accessing treatment or prevention in cross-border migrants, exploring preferences regarding location,
types of services, and opportunities to use health services in South Africa. Second, we will contact participants in
the LePHIA 2020 who identified as recent cross-border migrants and consented to be contacted for future research.
Eligible participants will be invited to complete a discrete choice experiment (DCE) on their preferences for
confirmatory testing after self- or other community-based testing, and linkage to treatment. The proposed study is
innovative because it is the first known attempt to use a DCE in a diverse panel of cross-border migrants, recruited
from the community rather than at health facilities. We will use findings to develop an intervention to support testing
and linkage in cross-border migrants.
项目摘要/摘要
在此R21应用程序中(PA-20-145:预防艾滋病毒,测试,依从性和保留的创新以优化
艾滋病毒预防和护理连续性结果),我们建议探索社区或家庭的使用
测试,包括自我测试(HIVST)和与跨性别测试和治疗联系的偏好
莱索托(Lesotho)的边界移民是一个非常高的艾滋病毒患病率,流动性高的国家。通过我们的
研究是2020年基于莱索托人群的艾滋病毒影响评估(Lephia)的一部分,我们发现
莱索托总体上在HIV病毒负荷抑制方面取得了巨大的收益,但是那些最近迁移的人
病毒抑制的可能性明显较小,这主要是由于缺乏意识。卫生部有
一直将HIVST推出,以此来吸引通常无法获得医疗保健的男子和人群。
但是,如果治疗的障碍意味着,测试的增加是不足以作为公共卫生策略
地位知识不会转化为参与抗逆转录病毒治疗和病毒抑制,
降低临床和流行控制益处。为了确定增加测试的最佳策略
并与移民的治疗率联系在一起,我们旨在确定验证性测试和治疗的偏好
在跨境移民中报告说,在设施外进行艾滋病毒测试是可以接受的。首先,我们将进行
形成性研究以探索移民健康的决定因素,并了解障碍和促进者
测试和访问跨境移民的治疗或预防,探索有关位置的偏好,
服务类型以及在南非使用卫生服务的机会。第二,我们将与参与者联系
Lephia 2020确定为最近的跨境移民,并同意与未来的研究联系。
符合条件的参与者将被邀请完成离散选择实验(DCE)的偏好
自我或其他基于社区的测试后的确认测试,并与治疗联系。拟议的研究是
创新性是因为它是在招募跨境移民小组中使用DCE的首次已知尝试
来自社区而不是医疗机构。我们将使用发现来开发干预措施来支持测试
和跨境移民的联系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yael R Hirsch-Moverman其他文献
Yael R Hirsch-Moverman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yael R Hirsch-Moverman', 18)}}的其他基金
Diabetes Evaluation in TB Patients in Eswatini for Improving TB/HIV Care and Treatment (DETECT) Study
斯威士兰结核病患者糖尿病评估以改善结核病/艾滋病毒护理和治疗 (DETECT) 研究
- 批准号:
10158678 - 财政年份:2021
- 资助金额:
$ 19.61万 - 项目类别:
Diabetes Evaluation in TB Patients in Eswatini for Improving TB/HIV Care and Treatment (DETECT) Study
斯威士兰结核病患者糖尿病评估以改善结核病/艾滋病毒护理和治疗 (DETECT) 研究
- 批准号:
10376842 - 财政年份:2021
- 资助金额:
$ 19.61万 - 项目类别:
Flexible InteRvention Strategy for TB prevention (FIRST) study
结核病预防的灵活干预策略(FIRST)研究
- 批准号:
10192655 - 财政年份:2020
- 资助金额:
$ 19.61万 - 项目类别:
Flexible InteRvention Strategy for TB prevention (FIRST) study
结核病预防的灵活干预策略(FIRST)研究
- 批准号:
10042345 - 财政年份:2020
- 资助金额:
$ 19.61万 - 项目类别:
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)
莱索托预防儿童结核病(预防研究)
- 批准号:
9060835 - 财政年份:2014
- 资助金额:
$ 19.61万 - 项目类别:
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)
莱索托预防儿童结核病(预防研究)
- 批准号:
8732171 - 财政年份:2014
- 资助金额:
$ 19.61万 - 项目类别:
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - Methods
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686544 - 财政年份:2023
- 资助金额:
$ 19.61万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 19.61万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 19.61万 - 项目类别:
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination
酒精或酒精/合成阿片类药物组合改变 HIV 药物代谢的治疗和机制意义
- 批准号:
10542286 - 财政年份:2022
- 资助金额:
$ 19.61万 - 项目类别: